Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer

NCT03220932 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT03220932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03220932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer
Lead sponsor
Hospices Civils de Lyon
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2019
Completion date
November 30, 2022
Enrollment
132 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian epithelial cancer